topical ipamorelin CJC-1295 and Peptide Injection Ipamorelin 5mg / 10mg Research

Severity of presentation depends on: Percentage of MetHb Rate of increase in MetHb levels The intrinsic ability of the patient to prevent or reduce MetHb The patients underlying functional status Symptoms depend on the level of MHb and its rapidity of formation, and include: 12 Dyspnea Anxiety Headache Fatigue Weakness CNS depression Dizziness Cyanosis Seizures Signs include: Cyanosis: As little as 1.5 g methemoglobin in 100 ml blood (1.5 g%) can produce clinically recognizable cyanosis

In combination, glutathione and CoQ10 have beneficial activity

10.1136/gutjnl-2020-322670 Gut

Patients require treatment soon after symptoms appear

10.1126/science.1661029